Madopar



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 33.3%
Parkinson's Disease 33.3%
Reflux Gastritis 33.3%
Drug Interaction 50.0%
Liver Disorder 50.0%
Secondary
Parkinson's Disease 59.6%
Drug Use For Unknown Indication 7.3%
Product Used For Unknown Indication 6.0%
Hypertension 3.6%
Pain 3.6%
Asthma 2.8%
Parkinsonism 2.3%
Drug Effect Decreased 2.0%
Cerebrovascular Accident 1.6%
Dementia 1.5%
Dementia With Lewy Bodies 1.3%
Antidepressant Therapy 1.2%
Anxiety 1.2%
Depression 1.1%
Restless Legs Syndrome 1.1%
Psychotic Disorder 0.9%
Benign Prostatic Hyperplasia 0.8%
Cardiac Failure 0.8%
Insomnia 0.8%
Type 2 Diabetes Mellitus 0.8%
Pathological Gambling 17.3%
Abnormal Behaviour 6.9%
Lethargy 6.4%
Pyrexia 5.8%
Thrombocytopenia 5.8%
Sopor 5.2%
Syncope 5.2%
Tremor 5.2%
Death 4.0%
Hallucination 4.0%
Liver Disorder 4.0%
Suicide Attempt 4.0%
White Blood Cell Count Decreased 4.0%
Completed Suicide 3.5%
Sudden Onset Of Sleep 3.5%
Theft 3.5%
Drug Interaction 2.9%
Hallucination, Visual 2.9%
Mental Disorder 2.9%
Nausea 2.9%
Concomitant
Parkinson's Disease 40.8%
Product Used For Unknown Indication 12.6%
Drug Use For Unknown Indication 12.5%
Hypertension 8.6%
Pain 2.7%
Constipation 2.7%
Depression 2.7%
Restless Legs Syndrome 2.2%
Osteoporosis 1.7%
Parkinsonism 1.7%
Diabetes Mellitus 1.7%
Renal Failure 1.7%
Hallucination 1.3%
Rheumatoid Arthritis 1.3%
Atrial Fibrillation 1.2%
Dementia 1.1%
Insomnia 1.0%
Drug Effect Decreased 0.9%
Asthma 0.8%
Type 2 Diabetes Mellitus 0.8%
Vomiting 10.7%
Parkinson's Disease 8.2%
Tremor 7.1%
Malaise 5.8%
Pneumonia 5.8%
Hypoglycaemia 5.2%
Loss Of Consciousness 5.2%
Progressive Multifocal Leukoencephalopathy 4.9%
Somnolence 4.7%
Atrial Fibrillation 4.4%
Sudden Onset Of Sleep 4.4%
General Physical Health Deterioration 4.1%
Hallucination 4.1%
White Blood Cell Count Increased 4.1%
Death 3.8%
Pyrexia 3.6%
Sepsis 3.6%
Vitreous Floaters 3.6%
Sopor 3.3%
Urinary Tract Infection 3.3%
Interacting
Product Used For Unknown Indication 29.7%
Parkinson's Disease 25.7%
Epilepsy 8.0%
Anaesthesia 4.6%
Restless Legs Syndrome 4.0%
Hypertension 3.4%
Depression 2.9%
Diuretic Therapy 2.3%
Gastritis Erosive 2.3%
Pain 2.3%
Thyroid Disorder 2.3%
Urinary Tract Infection 2.3%
Osteoporosis 1.7%
Reflux Gastritis 1.7%
Cardiac Failure 1.1%
Dyslipidaemia 1.1%
Muscle Spasms 1.1%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Secondary Hyperthyroidism 1.1%
Type 2 Diabetes Mellitus 1.1%
Drug Interaction 20.6%
Hallucination 11.8%
Serotonin Syndrome 8.8%
Gastrointestinal Haemorrhage 5.9%
Reflux Gastritis 5.9%
Transaminases Increased 5.9%
Tremor 5.9%
Depressed Level Of Consciousness 2.9%
Disorientation 2.9%
Fall 2.9%
Hallucination, Visual 2.9%
Headache 2.9%
Incorrect Drug Administration Rate 2.9%
Infectious Peritonitis 2.9%
Insomnia 2.9%
Peritonitis 2.9%
Restlessness 2.9%
Weight Decreased 2.9%
Wrong Drug Administered 2.9%